Hindustan Foods Ltd
Hindustan Foods Limited is an India-based company, which is engaged in contract manufacturing of various FMCG products including food, home care, personal care, beverages etc. They also do manufacturing of leather shoes and accessories
- Market Cap ₹ 6,220 Cr.
- Current Price ₹ 513
- High / Low ₹ 585 / 442
- Stock P/E 40.8
- Book Value ₹ 97.5
- Dividend Yield 0.00 %
- ROCE 14.2 %
- ROE 14.8 %
- Face Value ₹ 2.00
Pros
- Company has delivered good profit growth of 34.7% CAGR over last 5 years
Cons
- Stock is trading at 5.26 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last 3 years: -3.54%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| 492 | 772 | 1,386 | 2,040 | 2,598 | 2,755 | 3,564 | 4,251 | |
| 459 | 717 | 1,305 | 1,927 | 2,425 | 2,533 | 3,270 | 3,888 | |
| Operating Profit | 33 | 55 | 81 | 113 | 173 | 222 | 294 | 363 |
| OPM % | 7% | 7% | 6% | 6% | 7% | 8% | 8% | 9% |
| 1 | 1 | 3 | 4 | 5 | 7 | 15 | 9 | |
| Interest | 8 | 11 | 19 | 20 | 36 | 57 | 81 | 82 |
| Depreciation | 7 | 11 | 17 | 25 | 37 | 55 | 80 | 90 |
| Profit before tax | 18 | 34 | 48 | 71 | 104 | 117 | 148 | 200 |
| Tax % | 35% | 35% | 28% | 38% | 32% | 21% | 26% | 25% |
| 12 | 22 | 34 | 45 | 71 | 93 | 110 | 149 | |
| EPS in Rs | 1.76 | 2.07 | 3.25 | 3.96 | 6.31 | 8.12 | 9.33 | 12.47 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 25% |
| 3 Years: | 18% |
| TTM: | 19% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 35% |
| 3 Years: | 29% |
| TTM: | 42% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 1% |
| 3 Years: | -3% |
| 1 Year: | -7% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | 15% |
| Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 13 | 21 | 21 | 23 | 23 | 23 | 24 | 24 |
| Reserves | 51 | 165 | 199 | 281 | 352 | 623 | 868 | 1,141 |
| 100 | 165 | 218 | 350 | 516 | 727 | 892 | 1,088 | |
| 102 | 188 | 256 | 331 | 445 | 552 | 699 | 920 | |
| Total Liabilities | 266 | 539 | 694 | 984 | 1,335 | 1,924 | 2,483 | 3,174 |
| 133 | 250 | 271 | 427 | 554 | 908 | 1,012 | 1,302 | |
| CWIP | 0 | 26 | 53 | 87 | 125 | 9 | 120 | 150 |
| Investments | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 5 |
| 133 | 261 | 370 | 470 | 656 | 1,007 | 1,351 | 1,716 | |
| Total Assets | 266 | 539 | 694 | 984 | 1,335 | 1,924 | 2,483 | 3,174 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| -5 | 17 | 74 | 36 | 99 | 87 | 114 | 100 | |
| -40 | -145 | -92 | -139 | -220 | -381 | -289 | -339 | |
| 43 | 153 | 34 | 91 | 128 | 298 | 209 | 196 | |
| Net Cash Flow | -2 | 24 | 16 | -12 | 7 | 3 | 34 | -44 |
| Free Cash Flow | -46 | -111 | -5 | -104 | -65 | -46 | -118 | -225 |
| CFO/OP | -2% | 45% | 111% | 58% | 69% | 46% | 47% | 40% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 32 | 18 | 13 | 13 | 15 | 23 | 21 | 22 |
| Inventory Days | 54 | 74 | 58 | 56 | 68 | 98 | 121 | 106 |
| Days Payable | 84 | 94 | 74 | 64 | 69 | 85 | 84 | 69 |
| Cash Conversion Cycle | 2 | -2 | -2 | 5 | 14 | 37 | 58 | 59 |
| Working Capital Days | -8 | 7 | 5 | 4 | 6 | 17 | 32 | 36 |
| ROCE % | 17% | 17% | 17% | 18% | 15% | 14% | 14% |
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Number of Manufacturing Units Number |
|
||||||||
| Installed Capacity - Detergent Powder TPA |
|||||||||
| Installed Capacity - Extruded Food & Snacking TPA |
|||||||||
| Total Workforce Number |
|||||||||
| Gross Block (excluding CWIP, ROU, and Intangibles) Rs. Cr |
|||||||||
| Installed Capacity - Ice Cream Litres/year |
|||||||||
| Revenue Mix - Dedicated Manufacturing Percentage |
|||||||||
| Sales Volume - Shoe Division Rs. Cr |
|||||||||
Extracted by Screener AI
Documents
Announcements
- Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011 1d
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1d
- Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011 1d
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
1d - Audio recording of May 22, 2026 analyst call on Q4 and FY2026 performance uploaded.
- Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 1d
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Feb 2026Transcript PPT
-
Nov 2025Transcript PPT REC
-
Aug 2025Transcript PPT
-
May 2025Transcript PPT REC
-
Feb 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Aug 2023Transcript PPT
-
May 2023Transcript PPT
-
May 2023TranscriptAI SummaryPPT
-
Feb 2023Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptAI SummaryPPT
-
Aug 2022Transcript PPT
-
May 2022Transcript PPT
-
Feb 2022TranscriptAI SummaryPPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
May 2021Transcript PPT
-
Feb 2021Transcript PPT
-
Nov 2020Transcript PPT
-
Aug 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Jul 2020TranscriptAI SummaryPPT
-
Feb 2020TranscriptAI SummaryPPT
-
Nov 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Aug 2019TranscriptAI SummaryPPT
-
Mar 2018TranscriptAI SummaryPPT
Acquired by Van group[1] Hindustan Food Limited (HFL) started a joint venture between Glaxo Smith Kline and the Dempo group to manufacture a nutritional food product under the brand name of ‘Farex’ but the venture made losses for many years as it was dependent on a single brand. In 2013, Dempo Foods Pvt. Ltd., the Holding Company of Hindustan Foods Ltd was acquired by Vanity Case India Pvt. Ltd., and the latter bought 74.45% of the paid-up share capital.